Press Release March 22, 2023
Drugs for rare diseases announcement is a step forward for patients
Ottawa, March 22, 2023 – Innovative Medicines Canada (IMC) is encouraged by the federal government’s announcement regarding its intentions for […]
All News
Our news library that includes all press releases and industry related news.
Filter by
In the news February 28, 2023
The Clock is Ticking for Ottawa to Deliver on Its Rare Disease Strategy
This article originally appeared in Maclean’s print and healthinsights.ca on February 16, 2023 Canada desperately needs a rare disease strategy that’ll enable […]
Press Release February 14, 2023
A National Rare Disease Strategy Could Change Patients’ Lives
Ottawa, February 14, 2023 – With Rare Disease Day fast approaching, the federal government has an opportunity to make a […]
Press Release February 01, 2023
Appointment of PMPRB chair offers opportunity for meaningful stakeholder engagement
Ottawa, ON – Innovative Medicines Canada (IMC) welcomes the new leadership of the Patented Medicine Prices Review Board (PMPRB) with […]
In the news January 25, 2023
Major hurdles confront Canada’s Biomanufacturing and Life Sciences Strategy
This article originally appeared in Research Money on January 25, 2023. A dwindling workforce, inefficient regulations, and lack of much-needed […]
In the news January 13, 2023
Pharmaceutical Benefits: Ensuring Value for Plan Sponsors
We need to work together to evolve the private market so that it continues to have the value of providing […]
In the news December 20, 2022
Leave no patient behind: Ottawa must deliver on rare diseases
Pamela Fralick, President, Innovative Medicines Canada This article originally appeared in National Newswatch on December 20, 2022. In 2019, the […]
Press Release December 19, 2022
PMPRB Delay
an Opportunity for Meaningful Consultation
Ottawa, ON – Innovative Medicines Canada (IMC) welcomes the Patented Medicine Prices Review Board (PMPRB) announcement to delay the implementation […]
In the news December 15, 2022
Innovative medicines can transform lives, but only if they’re available to Canadians
Pamela Fralick, President, Innovative Medicines Canada *This article originally appeared in the Toronto Star on December 15, 2022. In 2016, […]
Press Release December 15, 2022
PMPRB leadership issues heighten need to suspend implementation of the revised draft Guidelines
Ottawa, ON – Following the resignation of the Patented Medicine Prices Review Board’s (PMPRB) Acting Chairperson last week, Innovative Medicines […]
Press Release December 05, 2022
Innovative Medicines Canada calls for a suspension of the PMPRB’s revised Draft Guidelines
Ottawa, ON – Innovative Medicines Canada (IMC) has submitted formal feedback to the Patented Medicine Prices Review Board’s (PMPRB) revised […]
Press Release November 22, 2022
PMPRB Continues to Mislead Canadians on the Value of Innovative Medicines
Ottawa, ON – Innovative Medicines Canada (IMC) is once again disappointed by the inaccurate and misleading information on the value […]
